MET and breast cancer: In contrast, osteolytic lesions were significantly decreased in tibiae injected with 4T1/sh c-Met BC cells (Fig. 7A, bottom, left and Fig. 7B) compared to tibiae injected with 4T1 parental or 4T1/sh control BC cells.